| Dec 11, 2025 |
Jan 21, 2026 |
Ways Douglas Kirk
|
Interim Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 31, 2025 |
Jan 5, 2026 |
Szwarcberg Javier B.
|
CEO |
Neutral |
90.0
|
+4,690
|
32.77%
|
✗
|
- |
| Dec 15, 2025 |
Dec 17, 2025 |
Gharib Samir M.
|
CFO |
Sell |
26.3
|
-362
|
-2.19%
|
✗
|
$29.2K |
| Dec 15, 2025 |
Dec 17, 2025 |
Szwarcberg Javier B.
|
CEO |
Sell |
22.5
|
-1,360
|
-4.63%
|
✗
|
$109.7K |
| Dec 11, 2025 |
Dec 15, 2025 |
SPIEGELMAN DANIEL K
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 11, 2025 |
Dec 15, 2025 |
GREY MICHAEL G
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 11, 2025 |
Dec 15, 2025 |
Gharib Samir M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 11, 2025 |
Dec 15, 2025 |
Szwarcberg Javier B.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 11, 2025 |
Dec 15, 2025 |
SIMPSON CAMILLA V
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 11, 2025 |
Dec 15, 2025 |
Barretto-Ko Percival
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 11, 2025 |
Dec 15, 2025 |
Walbert Keli
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 15, 2025 |
Walbert Keli
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 10, 2025 |
Dec 12, 2025 |
Gharib Samir M.
|
CFO |
Sell |
22.5
|
-864
|
-5.81%
|
✗
|
$75.9K |
| Dec 10, 2025 |
Dec 12, 2025 |
Szwarcberg Javier B.
|
CEO |
Sell |
22.5
|
-2,622
|
-10.14%
|
✗
|
$230.6K |
| Oct 20, 2025 |
Oct 22, 2025 |
Gharib Samir M.
|
CFO |
Sell |
22.5
|
-661
|
-9.83%
|
✗
|
$97.9K |
| Oct 20, 2025 |
Oct 22, 2025 |
Szwarcberg Javier B.
|
CEO |
Sell |
22.5
|
-1,539
|
-13.97%
|
✗
|
$228K |
| Oct 6, 2025 |
Oct 15, 2025 |
Parkman Healthcare Partners LLC
|
10% Owner |
Sell |
52.5
|
-1
|
-0.10%
|
✗
|
$335 |
|
Oct 15, 2025 |
Parkman Healthcare Partners LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 6, 2025 |
Oct 8, 2025 |
Parkman Healthcare Partners LLC
|
10% Owner |
Sell |
52.5
|
-1
|
-0.10%
|
✗
|
$335 |
|
Oct 8, 2025 |
Parkman Healthcare Partners LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 22, 2025 |
Jul 24, 2025 |
SPIEGELMAN DANIEL K
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 22, 2025 |
Jul 24, 2025 |
SIMPSON CAMILLA V
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 22, 2025 |
Jul 24, 2025 |
GREY MICHAEL G
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 22, 2025 |
Jul 24, 2025 |
Barretto-Ko Percival
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 22, 2025 |
Jul 24, 2025 |
Aynechi Tiba
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 23, 2025 |
Jul 24, 2025 |
Ways Kirk
|
Interim Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 22, 2025 |
Jul 24, 2025 |
Muralidhar Bali
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 10, 2024 |
Dec 20, 2024 |
Charlton Ralph William III
|
CHIEF MEDICAL OFFICER |
Sell |
26.3
|
-58,784
|
-12.12%
|
✗
|
$28.5K |
| Dec 10, 2024 |
Dec 20, 2024 |
Gharib Samir M.
|
CFO |
Sell |
26.3
|
-81,976
|
-7.73%
|
✗
|
$40K |
| Dec 10, 2024 |
Dec 20, 2024 |
Szwarcberg Javier B.
|
CEO |
Sell |
22.5
|
-199,630
|
-14.25%
|
✗
|
$96.6K |
| May 22, 2024 |
May 24, 2024 |
Ways Kirk
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2024 |
May 24, 2024 |
SPIEGELMAN DANIEL K
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2024 |
May 24, 2024 |
SIMPSON CAMILLA V
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2024 |
May 24, 2024 |
Muralidhar Bali
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2024 |
May 24, 2024 |
GREY MICHAEL G
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2024 |
May 24, 2024 |
Barretto-Ko Percival
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2024 |
May 24, 2024 |
Aynechi Tiba
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 21, 2024 |
Mar 25, 2024 |
Novo Holdings A/S
|
10% Owner |
Sell |
20.0
|
-465,021
|
-15.42%
|
✗
|
$351K |
| Mar 18, 2024 |
Mar 20, 2024 |
Novo Holdings A/S
|
10% Owner |
Sell |
17.5
|
-1,794,999
|
-37.32%
|
✗
|
$1.4M |
| Mar 14, 2024 |
Mar 18, 2024 |
Novo Holdings A/S
|
10% Owner |
Sell |
17.5
|
-1,912,316
|
-28.45%
|
✗
|
$1.7M |
| Mar 14, 2024 |
Mar 18, 2024 |
Charlton Ralph William III
|
CHIEF MEDICAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2024 |
Mar 18, 2024 |
Gharib Samir M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2024 |
Mar 18, 2024 |
Szwarcberg Javier B.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 29, 2023 |
Jan 3, 2024 |
Charlton Ralph William III
|
Chief Medical Officer |
Neutral |
90.0
|
+9,361
|
20.34%
|
✗
|
- |
| Dec 29, 2023 |
Jan 3, 2024 |
Gharib Samir M.
|
CFO |
Neutral |
85.0
|
+11,255
|
5.88%
|
✗
|
- |
| Dec 15, 2023 |
Dec 18, 2023 |
Charlton Ralph William III
|
Chief Medical Officer |
Sell |
26.3
|
-10,980
|
-19.27%
|
✗
|
$18.2K |
| Dec 15, 2023 |
Dec 18, 2023 |
Gharib Samir M.
|
CFO |
Sell |
22.5
|
-36,095
|
-9.14%
|
✗
|
$59.9K |
| Dec 15, 2023 |
Dec 18, 2023 |
Szwarcberg Javier B.
|
CEO |
Sell |
22.5
|
-38,384
|
-26.34%
|
✗
|
$63.7K |
| Nov 26, 2023 |
Nov 28, 2023 |
Szwarcberg Javier B.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 8, 2023 |
Nov 13, 2023 |
Gharib Samir M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 30, 2023 |
Jul 5, 2023 |
Charlton Ralph William III
|
Chief Medical Officer |
Neutral |
90.0
|
+12,378
|
96.22%
|
✗
|
- |
| Jun 30, 2023 |
Jul 5, 2023 |
Szwarcberg Javier B.
|
CEO |
Neutral |
90.0
|
+20,000
|
136.01%
|
✗
|
- |
| Jun 30, 2023 |
Jul 5, 2023 |
Gharib Samir M.
|
CFO |
Sell |
22.5
|
-15,452
|
-7.84%
|
✗
|
$55.8K |
| May 25, 2023 |
May 26, 2023 |
Ways Kirk
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 25, 2023 |
May 26, 2023 |
SPIEGELMAN DANIEL K
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 25, 2023 |
May 26, 2023 |
SIMPSON CAMILLA V
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 25, 2023 |
May 26, 2023 |
O'Donnell Niall
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 25, 2023 |
May 26, 2023 |
Muralidhar Bali
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 25, 2023 |
May 26, 2023 |
GREY MICHAEL G
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 25, 2023 |
May 26, 2023 |
Aynechi Tiba
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 25, 2023 |
May 26, 2023 |
Barretto-Ko Percival
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 26, 2023 |
Barretto-Ko Percival
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 16, 2023 |
May 16, 2023 |
O'Donnell Niall
|
Director |
Buy |
100.0
|
+630,400
|
90.59%
|
✗
|
$2M |
| Feb 16, 2023 |
Feb 21, 2023 |
Novo Holdings A/S
|
10% Owner |
Buy |
100.0
|
+2,208,000
|
48.91%
|
✗
|
$7M |
| Dec 30, 2022 |
Jan 5, 2023 |
Charlton Ralph William III
|
Chief Medical Officer |
Neutral |
90.0
|
+12,864
|
100.00%
|
✗
|
- |
| Dec 30, 2022 |
Jan 5, 2023 |
Szwarcberg Javier B.
|
CEO |
Neutral |
90.0
|
+14,705
|
100.00%
|
✗
|
- |
| Dec 30, 2022 |
Jan 5, 2023 |
Gharib Samir M.
|
CFO |
Sell |
26.3
|
-15,292
|
-14.60%
|
✗
|
$17.6K |
| Dec 5, 2022 |
Dec 7, 2022 |
Charlton Ralph William III
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 5, 2022 |
Dec 7, 2022 |
Gharib Samir M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 5, 2022 |
Dec 7, 2022 |
Szwarcberg Javier B.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 5, 2022 |
Gharib Samir M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 30, 2022 |
Jul 5, 2022 |
Gharib Samir M.
|
CFO |
Sell |
26.3
|
-7,522
|
-18.29%
|
✗
|
$22.6K |
| May 25, 2022 |
May 27, 2022 |
Aynechi Tiba
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 25, 2022 |
May 27, 2022 |
O'Donnell Niall
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 25, 2022 |
May 27, 2022 |
Muralidhar Bali
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 25, 2022 |
May 27, 2022 |
Ways Kirk
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 25, 2022 |
May 27, 2022 |
SPIEGELMAN DANIEL K
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 25, 2022 |
May 27, 2022 |
GREY MICHAEL G
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 25, 2022 |
May 27, 2022 |
Chaya Moghrabi Dina
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 25, 2022 |
May 27, 2022 |
SIMPSON CAMILLA V
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 1, 2022 |
Apr 1, 2022 |
Charlton Ralph William III
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 1, 2022 |
Charlton Ralph William III
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2022 |
Jan 10, 2022 |
Szwarcberg Javier B.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 10, 2022 |
Szwarcberg Javier B.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 31, 2021 |
Jan 5, 2022 |
Gharib Samir M.
|
CFO |
Buy |
90.0
|
+2,220
|
92.04%
|
✗
|
$8.4K |
| Dec 16, 2021 |
Dec 20, 2021 |
GREY MICHAEL G
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 16, 2021 |
Dec 20, 2021 |
Gharib Samir M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 16, 2021 |
Dec 20, 2021 |
Dias Subaweerage
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 30, 2021 |
Jul 6, 2021 |
KING RICHARD
|
CEO |
Buy |
91.3
|
+2,230
|
100.00%
|
✗
|
$21.2K |
| Jun 30, 2021 |
Jul 6, 2021 |
Gharib Samir M.
|
CFO |
Buy |
91.3
|
+1,412
|
100.00%
|
✗
|
$13.5K |
| Jun 23, 2021 |
Jun 25, 2021 |
Ways Kirk
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 25, 2021 |
Ways Kirk
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2021 |
May 21, 2021 |
SPIEGELMAN DANIEL K
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2021 |
May 21, 2021 |
SIMPSON CAMILLA V
|
Director |
Sell |
15.0
|
-334
|
-100.00%
|
✓
|
$5.1K |
| May 20, 2021 |
May 21, 2021 |
O'Donnell Niall
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2021 |
May 21, 2021 |
Muralidhar Bali
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2021 |
May 21, 2021 |
Chaya Moghrabi Dina
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2021 |
May 21, 2021 |
GREY MICHAEL G
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 19, 2021 |
May 21, 2021 |
Novo Holdings A/S
|
10% Owner |
Sell |
16.3
|
-475,000
|
-9.52%
|
✗
|
$6.6M |
| Apr 30, 2021 |
May 4, 2021 |
SIMPSON CAMILLA V
|
Director |
Sell |
10.0
|
-14,045
|
-100.00%
|
✓
|
$226.7K |